Yüklüyor......
Lamivudine resistance in children with chronic hepatitis B
Currently, although lamivudine (LAM) has a low genetic barrier, only interferon-alpha and LAM are available as a first-line treatment in children with chronic hepatitis B (CHB). LAM is a potent inhibitor of hepatitis B virus-deoxyribonucleic acid (HBV-DNA) polymerase replication by termination of th...
Kaydedildi:
| Yayımlandı: | World J Hepatol |
|---|---|
| Yazar: | |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2015
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4411531/ https://ncbi.nlm.nih.gov/pubmed/25937866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i6.896 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|